Following the news of two lecanemab-related deaths reported on the eve of the Clinical Trials on Alzheimer’s Disease (CTAD) 2022 conference, Eisai has now presented the full results from its ...

Biogen and Eisai have resurrected hopes that amyloid-targeting drugs could have a benefit in Alzheimer's disease with a claim that their new drug lecanemab showed a "highly statistically ...

Leqembi (lecanemab-irmb) is a prescription drug that’s used to treat Alzheimer’s disease. Leqembi comes as a liquid solution that’s given as an intravenous (IV) infusion. A healthcare ...

May 8, 2025 — The drugs, called NRTIs, have the potential to prevent a million cases of Alzheimer's every year, the researchers ... Sleep Apnea During REM Sleep Linked to Memory-Related Brain Ch ...

May 8, 2025 — The drugs, called NRTIs, have the potential to prevent a million cases of Alzheimer's every year, the researchers ... Sleep Apnea During REM Sleep Linked to Memory-Related Brain Ch ...

Inside the AAFP’s New Effort to Boost Primary Care Training This spring, AAFP announced a new initiative aimed to better understand the nation’s training programs in the field and how to ...

Neurodegenerative diseases are a heterogeneous group of disorders that are characterized by the progressive degeneration of the structure and function of the central nervous system or peripheral ...

Why Is Diagnostic Firm Hologic Stock Trading Higher On Tuesday? Why Is Teva Stock Trading Higher On Tuesday? Why Is Diagnostic Firm Hologic Stock Trading Higher On Tuesday? Why Is Teva Stock ...

That something is a medication called lecanemab. DENT administers it in its infusion center, through an IV only to patients with an early diagnosis of Alzheimer's. Center leaders say the drug attacks ...